Document is current
Any future updates will be listed below
-
Authors
Backes, Carl H.
Cooper, Jennifer N.
Notestine, Jennifer L.
Alfred, Crystal M.
Ball, Molly K.
Rivera, Brian K.
Lamp, Jane M.
Marzec, Laura
Stenger, Michael R.
Moallem, Mohannad
Miller, Randy R.
Naik, Apurwa
Beer, Lindsey J.
Howard, Christopher R. https://orcid.org/0000-0001-7187-5611
Welty, Stephen E.
Peter Richardson, C.
Hillman, Noah H.
Zupancic, John A. F. https://orcid.org/0000-0003-1734-7193
Stanberry, Larissa I.
Hansen, Thomas N.
Smith, Charles V.
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1094124)
- License Information
-
More Information
Article History
Received: 24 February 2020
Revised: 6 April 2020
Accepted: 7 May 2020
First Online: 20 May 2020
Compliance with ethical standards
:
: CPR, TNH, and CVS are included among the holders of patents on the Seattle-PAP device, specifically United States Patent #, under the title “Broad-band, low frequency, high-amplitude, long time duration, oscillating airway pressure breathing apparatus and method utilizing bubbles”. The patent is also registered with the World Intellectual Property Organization (PCT/US2009/039957), with patents or letters granted in several regions or countries, including Europe (), Korea (10–1,540,948), New Zealand (588682), China (201310269076.X), Canada (), Vietnam (13756), and India (7898/DELNP/2010). A patent has also been issued in Australia (2010241205) under a modified name. The rights to the Seattle-PAP device have been licensed to Draeger, Inc. CHB is a consultant for Abbott. The remaining authors have no other interests to declare.
